Targeted Modulation of Matrix‐Remodeling: Enzymes, Adhesion Receptors, and Signaling Hubs as Precision Strategies for Antifibrotic Therapy

ABSTRACT Liver fibrosis is increasingly recognized as a dynamic, spatially organized, and potentially reversible process of maladaptive wound healing rather than a passive consequence of collagen accumulation. Persistent liver injury activates multicellular fibrotic niches composed of hepatic stellate cells, macrophages, endothelial cells, fibrocytes, circulating myeloid populations, and extracellular matrix components that interact through reciprocal signaling networks. This review outlines a precision‐oriented antifibrotic framework centered on three interconnected target classes: matrix‐remodeling enzymes, adhesion receptors, and intracellular signaling hubs. Matrix metalloproteinases and tissue inhibitors of metalloproteinases regulate extracellular matrix turnover and determine whether fibrotic scars persist, remodel, or regress, indicating that productive fibrolysis should be restored rather than globally enhanced or suppressed. Adhesion receptors, particularly integrins, connect extracellular matrix composition and stiffness to intracellular mechanotransduction, latent TGF‐ β activation, hepatic stellate cell activation, and fibro‐inflammatory cell recruitment. Signaling hubs such as TGF‐ β \SMAD, GARP–TGF‐ β , FAK–RhoA/ROCK, PAK, NF‐ κ B, and YAP/TAZ integrate mechanical, inflammatory, and stromal cues into persistent profibrotic cellular states. Recent single‐cell, spatial transcriptomic, and spatial multi‐omics studies indicate that fibrosis is driven by disease‐specific cellular neighborhoods rather than uniform activation of single pathways or cell types. These findings support mechanism‐guided strategies that combine molecular target selection with spatial and temporal restriction to preserve physiological repair, immunity, regeneration, and tissue homeostasis. Future antifibrotic therapy will likely depend on identifying the dominant fibrotic niche in individual patients and selectively reprogramming the matrix, cell–matrix interface, and signaling networks that prevent fibrosis resolution.

Authors

Institutions

Publication Details

Journal
Journal of Cell Communication and Signaling
Published
2026-11-14
DOI
https://doi.org/10.1002/ccs3.70124
Primary Topic
Liver physiology and pathology
Type
article
Field-Weighted Citation Impact
0.00
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
NOV
article

Targeted Modulation of Matrix‐Remodeling: Enzymes, Adhesion Receptors, and Signaling Hubs as Precision Strategies for Antifibrotic Therapy

Elke Roeb, Ralf Weiskirchen
Journal of Cell Communication and Signaling
Liver physiology and pathology
article

Targeted Modulation of Matrix‐Remodeling: Enzymes, Adhesion Receptors, and Signaling Hubs as Precision Strategies for Antifibrotic Therapy

Elke Roeb, Ralf Weiskirchen
article en

Abstract

ABSTRACT Liver fibrosis is increasingly recognized as a dynamic, spatially organized, and potentially reversible process of maladaptive wound healing rather than a passive consequence of collagen accumulation. Persistent liver injury activates multicellular fibrotic niches composed of hepatic stellate cells, macrophages, endothelial cells, fibrocytes, circulating myeloid populations, and extracellular matrix components that interact through reciprocal signaling networks. This review outlines a precision‐oriented antifibrotic framework centered on three interconnected target classes: matrix‐remodeling enzymes, adhesion receptors, and intracellular signaling hubs. Matrix metalloproteinases and tissue inhibitors of metalloproteinases regulate extracellular matrix turnover and determine whether fibrotic scars persist, remodel, or regress, indicating that productive fibrolysis should be restored rather than globally enhanced or suppressed. Adhesion receptors, particularly integrins, connect extracellular matrix composition and stiffness to intracellular mechanotransduction, latent TGF‐ β activation, hepatic stellate cell activation, and fibro‐inflammatory cell recruitment. Signaling hubs such as TGF‐ β \SMAD, GARP–TGF‐ β , FAK–RhoA/ROCK, PAK, NF‐ κ B, and YAP/TAZ integrate mechanical, inflammatory, and stromal cues into persistent profibrotic cellular states. Recent single‐cell, spatial transcriptomic, and spatial multi‐omics studies indicate that fibrosis is driven by disease‐specific cellular neighborhoods rather than uniform activation of single pathways or cell types. These findings support mechanism‐guided strategies that combine molecular target selection with spatial and temporal restriction to preserve physiological repair, immunity, regeneration, and tissue homeostasis. Future antifibrotic therapy will likely depend on identifying the dominant fibrotic niche in individual patients and selectively reprogramming the matrix, cell–matrix interface, and signaling networks that prevent fibrosis resolution.

Journal of Cell Communication and SignalingVol. 20(4)
Justus-Liebig-Universität Gießen (DE), Universitätsklinikum Aachen (DE), RWTH Aachen University (DE)
Liver physiology and pathology
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.

Laika access coming soon